Market Closed -
Nasdaq
04:30:00 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
2.21
USD
|
-3.28%
|
|
+1.84%
|
+3.76%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
14.52
|
6.965
|
12.18
|
13.76
|
-
|
-
|
Enterprise Value (EV)
1 |
14.52
|
6.965
|
12.18
|
13.76
|
13.76
|
13.76
|
P/E ratio
|
-1.8
x
|
-1.47
x
|
-3.8
x
|
-3.3
x
|
-27.6
x
|
3.62
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
9.36
x
|
3.4
x
|
2.98
x
|
2.23
x
|
1.48
x
|
0.96
x
|
EV / Revenue
|
9.36
x
|
3.4
x
|
2.98
x
|
2.23
x
|
1.48
x
|
0.96
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-5,328,240
x
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-0%
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
5,565
|
5,572
|
5,718
|
6,228
|
-
|
-
|
Reference price
2 |
2.610
|
1.250
|
2.130
|
2.210
|
2.210
|
2.210
|
Announcement Date
|
3/21/22
|
3/28/23
|
4/1/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
1.551
|
2.048
|
4.089
|
6.17
|
9.323
|
14.28
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
-2.57
|
-3.348
|
-3.477
|
-4.129
|
-0.499
|
3.885
|
Operating Margin
|
-
|
-165.7%
|
-163.48%
|
-85.03%
|
-66.92%
|
-5.35%
|
27.2%
|
Earnings before Tax (EBT)
1 |
-
|
-4.31
|
-4.746
|
-3.188
|
-4.129
|
-0.499
|
3.885
|
Net income
1 |
-2.264
|
-4.31
|
-4.746
|
-3.157
|
-4.129
|
-0.499
|
3.885
|
Net margin
|
-
|
-277.89%
|
-231.74%
|
-77.21%
|
-66.92%
|
-5.35%
|
27.2%
|
EPS
2 |
-0.0300
|
-1.450
|
-0.8500
|
-0.5600
|
-0.6700
|
-0.0800
|
0.6100
|
Free Cash Flow
|
-
|
-2.726
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-175.76%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/31/21
|
3/21/22
|
3/28/23
|
4/1/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
0.533
|
0.396
|
0.561
|
0.568
|
0.524
|
0.62
|
1.167
|
1.221
|
1.082
|
1.207
|
1.405
|
1.691
|
1.867
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-0.887
|
-0.812
|
-0.718
|
-1.037
|
-0.781
|
-0.883
|
-0.762
|
-0.612
|
-1.219
|
-1.06
|
-1.042
|
-1.023
|
-1.003
|
Operating Margin
|
-166.42%
|
-205.05%
|
-127.99%
|
-182.57%
|
-149.05%
|
-142.42%
|
-65.3%
|
-50.12%
|
-112.66%
|
-87.82%
|
-74.16%
|
-60.5%
|
-53.72%
|
Earnings before Tax (EBT)
1 |
-1.639
|
-1.836
|
-1.035
|
-1.227
|
-0.648
|
-0.807
|
-0.642
|
-0.552
|
-1.187
|
-1.06
|
-1.042
|
-1.023
|
-1.003
|
Net income
1 |
-1.639
|
-1.836
|
-1.035
|
-1.227
|
-0.648
|
-0.814
|
-0.695
|
-0.552
|
-1.098
|
-1.06
|
-1.042
|
-1.023
|
-1.003
|
Net margin
|
-307.5%
|
-463.64%
|
-184.49%
|
-216.02%
|
-123.66%
|
-131.29%
|
-59.55%
|
-45.21%
|
-101.48%
|
-87.82%
|
-74.16%
|
-60.5%
|
-53.72%
|
EPS
2 |
-1.420
|
-0.3300
|
-0.1900
|
-0.2200
|
-0.1100
|
-0.1500
|
-0.1200
|
-0.1000
|
-0.2000
|
-0.1800
|
-0.1700
|
-0.1600
|
-0.1600
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/21/22
|
5/13/22
|
8/10/22
|
11/8/22
|
3/28/23
|
5/15/23
|
8/14/23
|
11/13/23
|
4/1/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-2.73
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
0.27
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
17.34%
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/31/21
|
3/21/22
|
3/28/23
|
4/1/24
|
-
|
-
|
-
|
Last Close Price
2.21
USD Average target price
6
USD Spread / Average Target +171.49% Consensus |
1st Jan change
|
Capi.
|
---|
| +3.76% | 13.76M | | +25.83% | 661B | | +27.00% | 566B | | -6.76% | 352B | | +20.34% | 332B | | +3.00% | 283B | | +13.09% | 231B | | +5.46% | 200B | | -9.61% | 195B | | -6.26% | 145B |
Other Pharmaceuticals
|